MDLN
Medline
$32.39
−$1.66 (−4.88%)Sep 10, 2026
Key metrics
The numbers that frame MDLN today
- Market cap
- $42.58B
- P/E (TTM)
- 61.4
- Gross margin
- 26.2%
- EV / Sales
- 1.8
- ROIC
- 5.9%
- Div yield
- 0%
- Debt / equity
- 1.1
Growth
Revenue and earnings trend for MDLN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MDLN
Is Medline a good buy?
Hold. Medline has mixed quality. Growth looks poor. That could put pressure on the long-term business case. We think Medline is selling at a fair price.
What is the market capitalization of MDLN?
Medline's market capitalization is $42.58B.
What is the P/E ratio for MDLN stock?
Medline's current P/E ratio is 61.4.
Does MDLN stock pay dividends?
Medline does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MDLN?
Medline's Debt / Equity ratio is 1.09.